Key Insights
The African nuclear imaging market, valued at $70.45 million in 2025, is projected to experience steady growth, driven by increasing prevalence of chronic diseases like cancer and cardiovascular ailments necessitating diagnostic imaging. This growth is further fueled by rising healthcare expenditure, improving healthcare infrastructure in select regions, and the expanding adoption of advanced imaging technologies like SPECT and PET scans. While a lack of skilled professionals and high equipment costs pose challenges, government initiatives aimed at improving healthcare access and the influx of foreign investment in medical infrastructure are expected to mitigate these restraints. The market segmentation reveals a significant share held by SPECT radioisotopes, particularly Technetium-99m, reflecting its widespread use in various diagnostic applications. PET radioisotopes are also experiencing growth, driven by their superior imaging capabilities, although their higher cost limits broader adoption. The application segment is dominated by SPECT applications, indicating strong demand for diagnostic procedures addressing common ailments.
Significant regional variations exist within Africa, with countries like South Africa, Kenya, and Egypt likely showcasing higher market penetration due to better healthcare infrastructure and economic conditions compared to other regions. The forecast period (2025-2033) anticipates sustained growth, albeit at a moderate pace, reflecting both the market's inherent growth potential and the persistent challenges mentioned above. Continued technological advancements in nuclear imaging, coupled with supportive government policies and increasing awareness about the benefits of early disease detection, are key factors driving this optimistic outlook. However, addressing the existing disparities in healthcare access across different African nations remains crucial for realizing the full market potential.
This comprehensive report provides an in-depth analysis of the Africa nuclear imaging industry, encompassing market dynamics, growth trends, key players, and future outlook. With a focus on both parent and child markets, this report is essential for industry professionals, investors, and researchers seeking to understand this rapidly evolving sector. The study period covers 2019-2033, with 2025 as the base and estimated year.

Africa Nuclear Imaging Industry Market Dynamics & Structure
The African nuclear imaging market is characterized by a moderately concentrated landscape, with key players like Siemens Healthineers, GE Healthcare, and Bracco Imaging SpA holding significant market share (estimated at xx% collectively in 2025). However, the market is witnessing increasing participation from smaller, specialized players, especially in radioisotope production and distribution.
- Market Concentration: Moderately concentrated, with larger players dominating equipment and some radioisotope segments.
- Technological Innovation: Driven by advancements in PET/CT and SPECT technologies, aiming for improved image resolution, faster scan times, and reduced radiation exposure. However, innovation is hampered by limited R&D investment and infrastructure challenges.
- Regulatory Framework: Varies across African nations, creating complexities for market entry and product standardization. Harmonization efforts are underway, but progress is gradual.
- Competitive Substitutes: Limited direct substitutes exist, but alternative diagnostic imaging modalities (e.g., MRI, Ultrasound) compete for healthcare budgets.
- End-User Demographics: Growing populations, rising prevalence of chronic diseases (cancer, cardiovascular diseases), and increased awareness of advanced diagnostic techniques drive market growth. However, uneven healthcare infrastructure and access across the continent remain significant limitations.
- M&A Trends: Moderate activity, with larger companies potentially acquiring smaller, specialized firms to expand their product portfolios and geographic reach. The number of M&A deals in the past five years is estimated at xx.
Africa Nuclear Imaging Industry Growth Trends & Insights
The African nuclear imaging market is experiencing robust growth, driven by factors such as increasing healthcare expenditure, rising prevalence of diseases requiring nuclear imaging, and government initiatives to improve healthcare infrastructure. The market size is projected to reach xx Million by 2033, registering a CAGR of xx% during the forecast period (2025-2033). This growth reflects a significant increase in adoption rates across various applications, particularly in oncology and cardiology. Technological disruptions, such as the introduction of advanced PET/CT scanners with improved resolution and faster scan times, are further accelerating market expansion. Changes in consumer behavior are also being observed, with patients becoming more aware of the benefits and limitations of nuclear imaging, leading to increased demand for improved imaging services and better patient care.

Dominant Regions, Countries, or Segments in Africa Nuclear Imaging Industry
South Africa currently leads the African nuclear imaging market, driven by advanced healthcare infrastructure, established research institutions, and a relatively higher per capita healthcare expenditure. However, other nations, such as Egypt, Nigeria, and Kenya, are witnessing rapid growth due to expanding healthcare budgets and increased investments in medical infrastructure.
By Product: Equipment segment holds the largest market share, followed by radioisotopes.
By Radioisotope: Technetium-99m (Tc-99m) dominates the SPECT radioisotope segment due to its widespread use in various applications. Fluorine-18 (F-18) is the leading PET radioisotope, reflecting the growing adoption of PET/CT scans.
By Application: Oncology applications (cancer diagnosis and staging) and cardiology (heart disease assessment) are the key drivers of market growth.
Key Growth Drivers:
- Increasing government investments in healthcare infrastructure.
- Rising prevalence of chronic diseases.
- Growing awareness among healthcare professionals and patients.
- Expansion of private healthcare sector.
Africa Nuclear Imaging Industry Product Landscape
The market offers a range of products including SPECT and PET scanners, radiopharmaceuticals, and related accessories. Recent innovations focus on improving image quality, reducing radiation exposure, and enhancing workflow efficiency. The development of novel radiotracers and improved imaging algorithms is transforming diagnostic capabilities. Unique selling propositions include faster scan times, better image resolution, and advanced image processing software that assists in diagnosis.
Key Drivers, Barriers & Challenges in Africa Nuclear Imaging Industry
Key Drivers: Rising prevalence of cancer and cardiovascular diseases, increasing government funding for healthcare infrastructure, and technological advancements in imaging technology.
Challenges: High initial investment costs for equipment, limited skilled personnel, insufficient regulatory frameworks in some regions, and dependence on imported radioisotopes. The cost of importing radioisotopes creates supply chain vulnerabilities and price volatility, estimated to impact profitability by approximately xx% in some regions.
Emerging Opportunities in Africa Nuclear Imaging Industry
Untapped markets in rural and underserved areas represent significant opportunities. Furthermore, the development of point-of-care diagnostic solutions, customized treatment plans using nuclear imaging data, and telemedicine integration are emerging trends with huge potential.
Growth Accelerators in the Africa Nuclear Imaging Industry Industry
Technological breakthroughs in PET/CT and SPECT imaging, coupled with strategic partnerships between multinational corporations and local healthcare providers, will accelerate market expansion. Targeted investments in training and education programs for healthcare professionals will further fuel growth.
Key Players Shaping the Africa Nuclear Imaging Industry Market
- CMR NAVISCAN (GAMMA MEDICA INC)
- Siemens Healthineers
- GE Healthcare
- Bracco Imaging SpA
- Cardinal Health Inc
- NTP Radioisotopes SOC
- Koninklijke Philips NV
- Nordion (Canada) Inc
- Canon Medical Systems Corporation
- Curium
Notable Milestones in Africa Nuclear Imaging Industry Sector
- June 2023: Launch of the South African Isotope Facility (SAIF), significantly boosting research and diagnostic capabilities.
- December 2022: MeCure Healthcare Limited installs its first cyclotron and PET-CT scan, enhancing access to advanced diagnostics.
In-Depth Africa Nuclear Imaging Industry Market Outlook
The African nuclear imaging market holds immense potential for future growth, driven by rising healthcare spending, technological advancements, and increasing awareness of advanced diagnostic techniques. Strategic partnerships, investments in infrastructure and training, and the development of tailored solutions for the African context are crucial for realizing this potential. The market is poised for significant expansion, offering lucrative opportunities for both established players and new entrants.
Africa Nuclear Imaging Industry Segmentation
-
1. Product
- 1.1. By Equipment
-
1.2. By Radioisotope
-
1.2.1. SPECT Radioisotopes
- 1.2.1.1. Technetium-99m (TC-99m)
- 1.2.1.2. Thallium-201 (TI-201)
- 1.2.1.3. Gallium (Ga-67)
- 1.2.1.4. Iodine (I-123)
- 1.2.1.5. Other SPECT Radioisotopes
-
1.2.2. PET Radioisotopes
- 1.2.2.1. Fluorine-18 (F-18)
- 1.2.2.2. Rubidium-82 (RB-82)
- 1.2.2.3. Other PET Radioisotopes
-
1.2.1. SPECT Radioisotopes
-
2. Application
-
2.1. SPECT Applications
- 2.1.1. Cardiology
- 2.1.2. Neurology
- 2.1.3. Thyroid
- 2.1.4. Other SPECT Applications
-
2.2. PET Applications
- 2.2.1. Oncology
- 2.2.2. Other PET Applications
-
2.1. SPECT Applications
Africa Nuclear Imaging Industry Segmentation By Geography
-
1. Africa
- 1.1. Nigeria
- 1.2. South Africa
- 1.3. Egypt
- 1.4. Kenya
- 1.5. Ethiopia
- 1.6. Morocco
- 1.7. Ghana
- 1.8. Algeria
- 1.9. Tanzania
- 1.10. Ivory Coast

Africa Nuclear Imaging Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 3.39% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rise in Prevalence of Chronic Diseases; Increase in Technological Advancements; Growth in Applications of Nuclear Medicine and Imaging
- 3.3. Market Restrains
- 3.3.1. Regulatory Issues; Lack of Reimbursement
- 3.4. Market Trends
- 3.4.1. Oncology Segment is Expected to Occupy a Significant Share in the Market
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Africa Nuclear Imaging Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Product
- 5.1.1. By Equipment
- 5.1.2. By Radioisotope
- 5.1.2.1. SPECT Radioisotopes
- 5.1.2.1.1. Technetium-99m (TC-99m)
- 5.1.2.1.2. Thallium-201 (TI-201)
- 5.1.2.1.3. Gallium (Ga-67)
- 5.1.2.1.4. Iodine (I-123)
- 5.1.2.1.5. Other SPECT Radioisotopes
- 5.1.2.2. PET Radioisotopes
- 5.1.2.2.1. Fluorine-18 (F-18)
- 5.1.2.2.2. Rubidium-82 (RB-82)
- 5.1.2.2.3. Other PET Radioisotopes
- 5.1.2.1. SPECT Radioisotopes
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. SPECT Applications
- 5.2.1.1. Cardiology
- 5.2.1.2. Neurology
- 5.2.1.3. Thyroid
- 5.2.1.4. Other SPECT Applications
- 5.2.2. PET Applications
- 5.2.2.1. Oncology
- 5.2.2.2. Other PET Applications
- 5.2.1. SPECT Applications
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Africa
- 5.1. Market Analysis, Insights and Forecast - by Product
- 6. South Africa Africa Nuclear Imaging Industry Analysis, Insights and Forecast, 2019-2031
- 7. Sudan Africa Nuclear Imaging Industry Analysis, Insights and Forecast, 2019-2031
- 8. Uganda Africa Nuclear Imaging Industry Analysis, Insights and Forecast, 2019-2031
- 9. Tanzania Africa Nuclear Imaging Industry Analysis, Insights and Forecast, 2019-2031
- 10. Kenya Africa Nuclear Imaging Industry Analysis, Insights and Forecast, 2019-2031
- 11. Rest of Africa Africa Nuclear Imaging Industry Analysis, Insights and Forecast, 2019-2031
- 12. Competitive Analysis
- 12.1. Market Share Analysis 2024
- 12.2. Company Profiles
- 12.2.1 CMR NAVISCAN (GAMMA MEDICA INC )
- 12.2.1.1. Overview
- 12.2.1.2. Products
- 12.2.1.3. SWOT Analysis
- 12.2.1.4. Recent Developments
- 12.2.1.5. Financials (Based on Availability)
- 12.2.2 Siemens Healthineers
- 12.2.2.1. Overview
- 12.2.2.2. Products
- 12.2.2.3. SWOT Analysis
- 12.2.2.4. Recent Developments
- 12.2.2.5. Financials (Based on Availability)
- 12.2.3 GE Healthcare
- 12.2.3.1. Overview
- 12.2.3.2. Products
- 12.2.3.3. SWOT Analysis
- 12.2.3.4. Recent Developments
- 12.2.3.5. Financials (Based on Availability)
- 12.2.4 Bracco Imaging SpA
- 12.2.4.1. Overview
- 12.2.4.2. Products
- 12.2.4.3. SWOT Analysis
- 12.2.4.4. Recent Developments
- 12.2.4.5. Financials (Based on Availability)
- 12.2.5 Cardinal Health Inc
- 12.2.5.1. Overview
- 12.2.5.2. Products
- 12.2.5.3. SWOT Analysis
- 12.2.5.4. Recent Developments
- 12.2.5.5. Financials (Based on Availability)
- 12.2.6 NTP Radioisotopes SOC
- 12.2.6.1. Overview
- 12.2.6.2. Products
- 12.2.6.3. SWOT Analysis
- 12.2.6.4. Recent Developments
- 12.2.6.5. Financials (Based on Availability)
- 12.2.7 Koninklijke Philips NV
- 12.2.7.1. Overview
- 12.2.7.2. Products
- 12.2.7.3. SWOT Analysis
- 12.2.7.4. Recent Developments
- 12.2.7.5. Financials (Based on Availability)
- 12.2.8 Nordion (Canada) Inc
- 12.2.8.1. Overview
- 12.2.8.2. Products
- 12.2.8.3. SWOT Analysis
- 12.2.8.4. Recent Developments
- 12.2.8.5. Financials (Based on Availability)
- 12.2.9 Canon Medical Systems Corporation*List Not Exhaustive
- 12.2.9.1. Overview
- 12.2.9.2. Products
- 12.2.9.3. SWOT Analysis
- 12.2.9.4. Recent Developments
- 12.2.9.5. Financials (Based on Availability)
- 12.2.10 Curium
- 12.2.10.1. Overview
- 12.2.10.2. Products
- 12.2.10.3. SWOT Analysis
- 12.2.10.4. Recent Developments
- 12.2.10.5. Financials (Based on Availability)
- 12.2.1 CMR NAVISCAN (GAMMA MEDICA INC )
List of Figures
- Figure 1: Africa Nuclear Imaging Industry Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Africa Nuclear Imaging Industry Share (%) by Company 2024
List of Tables
- Table 1: Africa Nuclear Imaging Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Africa Nuclear Imaging Industry Revenue Million Forecast, by Product 2019 & 2032
- Table 3: Africa Nuclear Imaging Industry Revenue Million Forecast, by Application 2019 & 2032
- Table 4: Africa Nuclear Imaging Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Africa Nuclear Imaging Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 6: South Africa Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: Sudan Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Uganda Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: Tanzania Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Kenya Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Rest of Africa Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Africa Nuclear Imaging Industry Revenue Million Forecast, by Product 2019 & 2032
- Table 13: Africa Nuclear Imaging Industry Revenue Million Forecast, by Application 2019 & 2032
- Table 14: Africa Nuclear Imaging Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 15: Nigeria Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: South Africa Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Egypt Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Kenya Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 19: Ethiopia Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Morocco Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 21: Ghana Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Algeria Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: Tanzania Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Ivory Coast Africa Nuclear Imaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Africa Nuclear Imaging Industry?
The projected CAGR is approximately 3.39%.
2. Which companies are prominent players in the Africa Nuclear Imaging Industry?
Key companies in the market include CMR NAVISCAN (GAMMA MEDICA INC ), Siemens Healthineers, GE Healthcare, Bracco Imaging SpA, Cardinal Health Inc, NTP Radioisotopes SOC, Koninklijke Philips NV, Nordion (Canada) Inc, Canon Medical Systems Corporation*List Not Exhaustive, Curium.
3. What are the main segments of the Africa Nuclear Imaging Industry?
The market segments include Product, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD 70.45 Million as of 2022.
5. What are some drivers contributing to market growth?
Rise in Prevalence of Chronic Diseases; Increase in Technological Advancements; Growth in Applications of Nuclear Medicine and Imaging.
6. What are the notable trends driving market growth?
Oncology Segment is Expected to Occupy a Significant Share in the Market.
7. Are there any restraints impacting market growth?
Regulatory Issues; Lack of Reimbursement.
8. Can you provide examples of recent developments in the market?
In June 2023, the South African Minister of Higher Education, Science, and Innovation launched the South African Isotope Facility (SAIF) to enhance cancer research, diagnostics, and treatment in the country. Further, as per the minister, SAIF is supported and funded by the Department of Science and Innovation (DSI).
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Africa Nuclear Imaging Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Africa Nuclear Imaging Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Africa Nuclear Imaging Industry?
To stay informed about further developments, trends, and reports in the Africa Nuclear Imaging Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence